Detalhe da pesquisa
1.
A low thrombospondin-1 serum concentration is related to increased bacteremia risk in lymphoma patients treated with BeEAM/BEAM conditioning regimen and autologous stem cell transplantation.
Transpl Infect Dis
; 26(1): e14212, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-38112043
2.
Serum Levels of miR-122-5p and miR-125a-5p Predict Hepatotoxicity Occurrence in Patients Undergoing Autologous Hematopoietic Stem Cell Transplantation.
Int J Mol Sci
; 25(8)2024 Apr 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-38673940
3.
An elevated systemic inflammation index is related to an inferior response to pomalidomide and dexamethasone treatment in patients with relapsed and refractory multiple myeloma.
Contemp Oncol (Pozn)
; 27(3): 139-146, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-38239862
4.
MicroRNAs predict early complications of autologous hematopoietic stem cell transplantation.
Biomark Res
; 12(1): 42, 2024 Apr 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-38650024
5.
Neutrophil to lymphocyte ratio (NLR) impact on the progression-free survival and overall survival of multiple myeloma patients treated with high-dose chemotherapy and autologous stem cell transplantation.
Leuk Lymphoma
; 64(1): 98-106, 2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36318865
6.
High serum miR-223-3p expression level predicts complete response and prolonged overall survival in multiple myeloma patients undergoing autologous hematopoietic stem cell transplantation.
Front Oncol
; 13: 1250355, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37829335
7.
Risk Factors of Infection in Relapsed/Refractory Multiple Myeloma Patients Treated with Lenalidomide and Dexamethasone (Rd) Regimen: Real-Life Results of a Large Single-Center Study.
J Clin Med
; 11(19)2022 Oct 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-36233774
8.
Prognostic Value of Resistance Proteins in Plasma Cells from Multiple Myeloma Patients Treated with Bortezomib-Based Regimens.
J Clin Med
; 10(21)2021 Oct 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-34768548